Hirtle Callaghan & Co’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-478
Closed -$31K 172
2017
Q3
$31K Hold
478
﹤0.01% 124
2017
Q2
$30K Sell
478
-118
-20% -$7.45K ﹤0.01% 97
2017
Q1
$36K Hold
596
0.01% 102
2016
Q4
$34K Sell
596
-388
-39% -$22.9K 0.01% 87
2016
Q3
$57K Hold
984
0.01% 132
2016
Q2
$57K Sell
984
-3,100
-76% -$178K 0.01% 114
2016
Q1
$247K Sell
4,084
-295
-7% -$16.5K 0.05% 80
2015
Q4
$239K Sell
4,379
-190
-4% -$10.9K 0.06% 41
2015
Q3
$260K Hold
4,569
0.04% 49
2015
Q2
$249K Buy
+4,569
New +$251K 0.08% 60

Other funds holding DOX

Hirtle Callaghan & Co's DOX Position: Q4 2017 in Review

Hirtle Callaghan & Co sold out of Amdocs (DOX) in Q4 2017, closing a stake of 478 shares — an estimated $31K sold.

Hirtle Callaghan & Co first reported a position in DOX in Q2 2015 and held it in 10 quarters. The position peaked at $260K in Q3 2015. 387 funds tracked by Wall St. Rank hold DOX as of Q4 2017.

  • Hirtle Callaghan & Co reported no remaining Amdocs position as of Q4 2017 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 478 Amdocs shares in Q4 2017, an estimated $31K.
  • Hirtle Callaghan & Co first reported a position in Amdocs in Q2 2015 and held it in 10 quarters.
  • Hirtle Callaghan & Co's Amdocs position peaked at $260K in Q3 2015.
  • 387 funds tracked by Wall St. Rank held Amdocs as of Q4 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.